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Abstract Autotaxin (NPP2) is a tumor cell motility-stimulat-
ing factor that displays both a nucleotide pyrophosphatase/phos-
phodiesterase activity and a recently described lysophospholi-
pase D activity. The hydrolysis of nucleotides is a metal-
assisted reaction that occurs via a nucleotidylated threonine in
the catalytic site. We show here that the catalytic site threonine
and the metal-coordinating residues are also essential for the
hydrolysis of lysophospholipids. In comparing the substrate
speci¢city of NPP2 and the closely related NPP1 and NPP3,
we found that only NPP2 displayed a lysophospholipase D ac-
tivity, whereas NPP1 and NPP3 had a much higher nucleotide
pyrophosphatase activity.
( 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Nucleotide pyrophosphatases/phosphodiesterases (NPPs)
are ubiquitous membrane-associated or secreted ectoenzymes
that release nucleoside 5P-monophosphate from a variety of
nucleotides and nucleotide derivatives [1]. The mammalian
NPP family comprises ¢ve members but only three of these
(NPP1^3) have been studied in some detail. NPP1 has a reg-
ulatory function in bone mineralization and this stems from
its ability to convert ATP into AMP and PPi, the latter being
an inhibitor of calci¢cation [2]. A loss of functional NPP1 is
associated with hypermineralization abnormalities such as os-
teoarthritis and ossi¢cation of the posterior longitudinal liga-
ment of the spine [3,4]. NPP2 or autotaxin was originally
identi¢ed as an autocrine motility-stimulating factor that is
secreted by melanoma cells [5,6]. Later, NPP2 was also shown
to augment the carcinogenic and metastatic potential of ras-
transformed cells [7,8]. These e¡ects of NPP2 cannot be ex-
plained by the hydrolysis of nucleotides but have recently
been attributed to an intrinsic lysophospholipase D activity,
resulting in the hydrolysis of extracellular lysophosphatidyl-
choline (lysoPC) into lysophosphatidic acid (lysoPA) and cho-
line [9,10]. LysoPA, via G protein-coupled receptors, elicits
hormone and growth factor-like responses in almost every
cell type and orchestrates chemotaxis, invasiveness and pro-
liferation of cancer cells [10^13]. The third NPP isoform,
NPP3, has also been shown to a¡ect the morphology and
invasive properties of ¢broblasts and glioma cells but the
underlying mechanism is unknown [14].
NPPs belong to a superfamily of phospho/sulfo-coordinat-
ing metalloenzymes that also includes alkaline phosphatases
[15,16]. Based on structural similarities with better character-
ized members of this superfamily we have identi¢ed residues
that are essential for the nucleotide pyrophosphatase/phos-
phodiesterase reaction [16]. The recent description of NPP2
as a lysophospholipase D prompted us to examine whether
lysophospholipids and nucleotides, which both contain a
phosphodiester bond, were hydrolyzed by the same or by
di¡erent catalytic sites. The present study shows that both
enzyme activities of NPP2 are mediated by a single catalytic
site. Surprisingly, in spite of the structural similarities of
NPP1^3, only NPP2 acted as a lysophospholipase D, whereas
NPP1 and NPP3 were much better nucleotide pyrophospha-
tases/phosphodiesterases.
2. Materials and methods
2.1. Reagents
Snake venom phosphodiesterase I from Crotalus atrox (crude dried
venom), monoclonal myc tag antibodies (clone 9E10), monoclonal
hemagglutinin (HA) tag antibodies (clone HA-7), p-nitrophenylphos-
phate (pNPP), p-nitrophenyl thymidine 5P-monophosphate (pNP-
TMP) and C14:0 lysoPC were purchased from Sigma. Bis(p-nitrophe-
nyl)phosphate (bis-pNPP) was obtained from Aldrich.
2.2. NPP constructs
The mouse NPP1 coding sequence (residues 35^905), obtained from
the pSVL/PC-1 plasmid [17], was subcloned in a modi¢ed pEGFP-N1
vector (Clontech), thereby fusing mouse NPP1 to an HA tag
(YPYDVPDYA) at its N-terminal end and to enhanced green £uo-
rescent protein (EGFP) at its C-terminal end. The cDNAs for rat
NPP2L and rat NPP3, the latter obtained from Dr. H. Deissler (Uni-
versity of Essen, Germany), were similarly subcloned in this modi¢ed
EGFP-N1 vector. To construct C-terminally myc-tagged NPP iso-
forms, the cDNA encoding EGFP was cut using BamHI-NotI and
replaced by an adapter encoding the amino acid residues 410^419
(EQKLISEEDL) of the human c-myc. Point mutations in the catalytic
domain of rat NPP2L were introduced with the QuickChange site-
directed mutagenesis protocol (Stratagene). All polymerase chain re-
action ampli¢cations were conducted using Pwo-proofreading poly-
merase (Roche Diagnostics). All mutations and subcloning steps
were veri¢ed by DNA sequencing.
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2.3. Expression of wild-type and mutant NPPs
COS-1 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
containing 10% (v/v) fetal bovine serum and 100 U/ml each of pen-
icillin and streptomycin. Cells were transfected at 30^40% con£uence,
using the FuGene16 reagent (Roche Diagnostics). Transiently over-
expressed NPP proteins were harvested after 48^72 h. The cells were
washed twice in ice-cold phosphate-bu¡ered saline (PBS) and lysed in
20 mM Tris^HCl at pH 7.5, 0.5 mM phenylmethylsulfonyl £uoride,
0.5 mM benzamidine, 0.3 M NaCl and 0.2% Triton X-100. After
centrifugation (5 min at 5000Ug) the supernatant was used for im-
munoprecipitation of the myc-tagged fusions with monoclonal myc
tag antibodies and protein A-TSK (A⁄land). The immunoprecipitates
were washed once with 0.25 M LiCl and twice with ice-cold Tris-
bu¡ered saline (TBS), resuspended in TBS and used for Western anal-
ysis or assayed for speci¢ed enzymatic activity. Secreted NPP1^3 were
immunocaptured in the medium using myc tag antibodies (clone
9E10) and subsequently precipitated using protein A-TSK.
2.4. Western analysis
Following sodium dodecyl sulfate^polyacrylamide gel electrophore-
sis (SDS^PAGE) on 7.5% tricine gels, proteins were electroblotted
onto polyvinylidene di£uoride membranes (Amersham Bioscience) at
39 V in 50 mM Tris base supplemented with 50 mM boric acid (pH
8.3). Aspeci¢c binding sites were blocked using 0.2% (v/v) Triton X-
100 and 5% (w/v) powdered milk in PBS. Myc-tagged fusion proteins
were detected by clone 9E10 monoclonal antibodies, HA-tagged pro-
teins were visualized by clone HA-7 monoclonal antibodies or clone
12CA5 monoclonal antibodies. Peroxidase-labelled secondary anti-
bodies were used for chemiluminescent detection.
2.5. Enzymic activities of NPPs
The nucleotide pyrophosphatase/phosphodiesterase activity was
measured with pNP-TMP or ATP as substrates [15]. The NPP iso-
forms were incubated at 37‡C in the presence of 100 mM Tris^HCl at
pH 8.9 and either 5 mM pNP-TMP or 50 WM [Q-32P]ATP. The hy-
drolysis of pNP-TMP was stopped by a 10-fold dilution in 3% (w/v)
trichloroacetic acid. Subsequently, the reaction mixture was neutral-
ized with 60 Wl 5 N NaOH and the formed p-nitrophenol (pNP) was
quanti¢ed colorimetrically at 405 nm. The hydrolysis of ATP was
arrested by the addition of 100 mM EDTA. One Wl of the reaction
mixture was analyzed by thin-layer chromatography on polyethylene-
imine cellulose plates (Merck). Nucleotides and degradation products
were separated by ascending chromatography in 750 mM KH2PO4 at
pH 3.0. Radioactive spots were visualized by autoradiography. The
nucleotidylated intermediate, formed during the hydrolysis of 50 WM
[K-32P]ATP, was trapped according to Blytt et al. [18], with slight
modi¢cations [16]. Following SDS^PAGE, the trapped intermediate
was visualized by autoradiography.
Bis-pNPP and pNPP were also tested as substrates for NPP1^3. The
NPP isoforms were incubated in 100 mM Tris^HCl at pH 8.9 and
either 5 mM bis-pNPP or pNPP for 2.5 h at 37‡C. Subsequently, the
formed pNP was quanti¢ed colorimetrically at 405 nm.
The lysophospholipase D activity was determined as described by
Umezu-Goto et al. [10]. Equal amounts of the immunoprecipitated
NPPs were incubated for 12 h at room temperature with 2 mM C14:0
lysoPC from egg (Sigma) in 100 mM Tris^HCl at pH 8.9, 5 mM
MgCl2, 5 mM CaCl2, 500 mM NaCl and 0.05% Triton X-100. The
liberated choline was detected by an enzymic colorimetric method
using choline oxidase, horseradish peroxidase and TOOS reagent
(N-ethyl-N-(2-hydroxy-3-sulfoproryl)-3-methylaniline) as a hydrogen
donor. The purple color was quanti¢ed at 540 nm using a 96-well
plate reader.
3. Results
3.1. NPP2 hydrolyzes nucleotides and lysophospholipids in the
same catalytic site
In accordance with recently published data [9,10], NPP2
expressed in COS-1 cells with a C-terminal myc tag and pre-
cipitated from the culture medium with myc tag antibodies
displayed a lysophospholipase D activity (Fig. 1). The cata-
lytic site threonine, which is nucleotidylated during the nucle-
otide pyrophosphatase/phosphodiesterase reaction, also ap-
peared to be essential for the lysophospholipase D activity
of NPP2. Indeed, the T207A mutant had no detectable lyso-
phospholipase D activity whereas the T207S mutant only
showed 15% of the wild-type activity. Since the catalytic site
threonine has also been shown to be essential for the motility-
stimulating properties of NPP2 [7,19], these data are further
evidence for a contribution of the lysophospholipase D activ-
ity to motility stimulation.
We have previously identi¢ed residues that coordinate two
metals in the catalytic domain of NPP1 [16]. These residues
are also conserved in NPP2 and we found that mutation of
residues involved in the coordination of either Me1 (D309N,
H313Q) or Me2 (D169N) completely abolished the nucleotide
pyrophosphatase/phosphodiesterase (not shown) and lyso-
phospholipase D activities of NPP2 (Fig. 1). However, the
H313Q mutant still showed 20% of the wild-type activity
when assayed in the presence of 1 mM ZnCl2, which is strong
evidence that the e¡ect of this mutation stems from the loss of
a metal rather than from gross conformational changes.
The above data indicate that NPP2 hydrolyzes nucleotides
and lysophospholipids by the same mechanism in a single
catalytic site. In further agreement with this proposal, the
hydrolysis of both substrates by NPP2 was severely reduced
by metal chelators such as EDTA (data not shown) or EGTA
[11,20]. Both activities were also severely compromised by the
histidine acylator diethylpyrocarbonate (not shown), in keep-
ing with the role of histidines (e.g. H313, see Fig. 1) in catal-
Fig. 1. The lysophospholipase D activity of catalytic site mutants of
NPP2. Rat NPP2 or the indicated mutants were expressed in COS-1
cells as fusions with a C-terminal myc tag, and immunoprecipitated
from the culture medium with myc tag antibodies. D309N and
H313Q are predicted to coordinate Me1, whereas D169N is believed
to coordinate Me2. Equal amounts of immunoprecipitated fusion
proteins, as judged by Western analysis with myc tag antibodies
(A), were used for the assay of lysophospholipase D using lysoPC
as substrate in the absence (open bars) or presence (shaded bars) of
1 mM of ZnCl2 (B). The results represent the meansUS.E.M. of six
independent assays. The myc tag antibodies did not precipitate any
detectable lysophospholipase D activity from mock-transfected cells
(data not shown). Wt, wild-type.
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ysis [16]. Furthermore, both activities were similarly blocked
by vanadate (not shown).
3.2. Substrate speci¢city of NPP1^3
Since NPP1^3 are structurally closely related and have all
independently been reported to hydrolyze nucleotides, this
raised the possibility that NPP1 and NPP3, like NPP2, also
displayed a lysophospholipase D activity. The report that
NPP3 [14], like NPP2, a¡ects cell motility and invasive prop-
erties was also suggestive for an overlapping substrate speci-
¢city. To compare the substrate speci¢city of NPP1, NPP2
and NPP3, the rodent isoforms were expressed in COS-1 cells,
with both an N-terminal HA tag and a C-terminal myc tag.
All three isoforms were detected both in the medium and in
cell lysates (Fig. 2). However, whereas NPP1 and NPP3 were
mainly present in the cell lysates, NPP2 was predominantly
detected as a soluble protein in the culture medium. The solu-
ble NPP isoforms could not be detected with HA tag anti-
bodies, in keeping with reports that soluble NPPs are gener-
ated from the membrane-associated forms by the proteolytic
removal of the N-terminus [6,21,22].
Following immunoprecipitation of the soluble and mem-
brane-associated NPPs with myc tag antibodies, the respective
isoforms were used for a comparative analysis of substrate
speci¢cities. At similar concentrations of the membrane-asso-
ciated (not shown) or soluble NPPs, as determined by West-
ern analysis (Fig. 3A), only NPP2 displayed a lysophospholi-
pase D activity (Fig. 3B). On the other hand, the classical
nucleotide phosphodiesterase substrate, pNP-TMP, was read-
ily hydrolyzed by NPP1 but was a three- and six-fold poorer
substrate for NPP3 and NPP2, respectively (Fig. 3C). Simi-
larly, whereas NPP1 e⁄ciently hydrolyzed ATP into AMP
and PPi (Fig. 3D), NPP3 was less active towards this substrate
and the ATP-hydrolyzing activity of NPP2 was barely detect-
able. The latter data were corroborated by ¢ndings that the
adenylated catalytic intermediate in the presence of imidazole
could be readily visualized for NPP1 (Fig. 3D), whereas the
covalent intermediate of ATP hydrolysis by NPP3 and NPP2
was only detected at prolonged exposure times (not shown).
Another substrate that has classically been used to assay nu-
cleotide pyrophosphatases/phosphodiesterases is bis-pNPP
[23]. This is an unusual substrate in that it is neither a nucle-
otide nor a lysophospholipid derivative. Surprisingly, NPP2
was able to hydrolyze bis-pNPP whereas both NPP1 and
NPP3 were totally ine¡ective (Fig. 3E). One of the products
of the hydrolysis of bis-pNPP is pNPP, a classical in vitro
substrate for alkaline phosphatases. In spite of the structural
and catalytic similarities between NPPs and alkaline phospha-
tases, none of the NPPs was able to hydrolyze pNPP (not
shown).
We also tested all of the above-mentioned substrates with
snake venom phosphodiesterase I. Snake venom phosphodies-
terases from di¡erent sources have previously been demon-
strated to display catalytic properties similar to those of
NPP1 and NPP3 [24,25]. Surprisingly, all of the above sub-
strates, except pNPP, were readily hydrolyzed by the snake
venom phosphodiesterase I. Also, when [K-32P]ATP was used
as a substrate, the adenylated catalytic intermediate could be
visualized in the presence of imidazole (not shown). Thus,
snake venom phosphodiesterase I appears to have a much
broader substrate speci¢city than the mammalian NPP1^3.
4. Discussion
We have shown here that the lysophospholipase D and nu-
cleotide pyrophosphatase/phosphodiesterase activities of
NPP2 are similarly a¡ected by mutation of catalytic site res-
idues (Fig. 1) and by metal-chelating and histidine-modifying
agents. This is strong evidence that both activities stem from
the same catalytic site. The only structural feature that all
known NPP substrates have in common is a diester- or py-
rophosphate-bonded phosphate group (Fig. 3). Thus, the cat-
alytic site of NPPs appears to be capable of hydrolyzing phos-
phodiester and pyrophosphate bonds in a broad range of
substrates. Interestingly, whereas the snake venom phospho-
diesterase I hydrolyzed all tested substrates, the mammalian
Fig. 2. The expression of NPP1^3 as membrane-associated and secreted proteins in COS-1 cells. NPP1^3 were expressed in COS-1 cells as fu-
sion proteins with both an N-terminal HA tag and a C-terminal myc tag. The expression levels of the NPPs in the cell lysate and the culture
medium were quanti¢ed by Western analysis with HA tag (left panel) and myc tag (right panel) antibodies. Equal volumes (10 Wl) of cell lysate
and culture medium were applied.
C
Fig. 3. The substrate speci¢city of NPP1, NPP2 and NPP3. The secreted NPP fusions (Fig. 2) were immunoprecipitated with myc tag antibod-
ies. Equal amounts of the immunoprecipitated proteins, as judged by Western analysis with myc tag antibodies (A), were used for the assay of
enzymic activities with lysoPC (B), pNP-TMP (C), [Q-32P]ATP (D) or bis-pNPP (E) as substrates. The results represent the meansUS.E.M. of
three to six independent assays. Panel D also shows the adenylated catalytic intermediate of the hydrolysis of [K-32P]ATP that was trapped in
the presence of imidazole. Similar data were obtained with the NPPs immunoprecipitated from cell lysates (not shown). The ¢gure also shows
the structure of the used NPP substrates; the phosphodiester or pyrophosphate bonds that are hydrolyzed by NPPs are indicated by an arrow.
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NPPs showed a remarkable substrate speci¢city (Fig. 3). It is
reassuring that the observed in vitro substrate speci¢cities
correspond nicely to known biological functions of NPPs.
Thus, NPP1 is by far the best ATP-hydrolyzing isoform in
vitro (Fig. 3) and convincing evidence shows that NPP1 also
hydrolyzes this substrate in vivo (see Section 1). Similarly, the
cell motility e¡ects of NPP2 have been attributed to its lyso-
phospholipase D activity and we found that NPP2 is the only
NPP isoform with this activity.
It is currently unknown what determines the substrate spec-
i¢city of the NPPs. Since we have compared NPP1^3 from the
same source, it can be excluded that the observed di¡erences
in substrate speci¢city stem from the use of di¡erent expres-
sion systems or from the use of soluble versus membrane-
associated enzymes. It therefore seems likely that the substrate
speci¢city of NPP1^3 is determined by substrate recognition
motifs. For example, NPP1 and NPP3 contain a so-called
GxGxxG motif that is also found in protein kinases and other
nucleotide-binding proteins, and that may well be involved in
the recognition of nucleotides as substrates [1]. Interestingly,
NPP2 lacks this motif which could explain why this isoform is
a poor nucleotide pyrophosphatase/phosphodiesterase. We
speculate that NPP2 contains a lysophospholipid-binding mo-
tif.
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